Personalised reimbursement: A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients

S. B. Van Waalwijk Van Doorn-Khosrovani; A. Pisters-Van Roy; L. Van Saase; M. Van Der Graaff; J. Gijzen; S. Sleijfer; L. R. Hoes; J. M. Van Berge Henegouwen; H. Van Der Wijngaart; D. L. Van Der Velden; E. Van Werkhoven; V. P. Retel; W. H. Van Harten; A. D.R. Huitema; L. Timmers; H. Gelderblom; H. M.W. Verheul; E. E. Voest

doi:10.1093/annonc/mdz119

Personalised reimbursement: A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients

S. B. Van Waalwijk Van Doorn-Khosrovani, A. Pisters-Van Roy, L. Van Saase, M. Van Der Graaff, J. Gijzen, S. Sleijfer, L. R. Hoes, J. M. Van Berge Henegouwen, H. Van Der Wijngaart, D. L. Van Der Velden, E. Van Werkhoven, V. P. Retel, W. H. Van Harten, A. D.R. Huitema, L. Timmers, H. Gelderblom, H. M.W. Verheul, E. E. Voest^*

^*Corresponding author for this work

Health Technology & Services Research

Research output: Contribution to journal › Editorial › Academic › peer-review

25 Citations (Scopus)

63 Downloads (Pure)

Original language	English
Pages (from-to)	663-665
Number of pages	3
Journal	Annals of oncology
Volume	30
Issue number	5
Early online date	26 Apr 2019
DOIs	https://doi.org/10.1093/annonc/mdz119
Publication status	Published - 1 May 2019

Keywords

UT-Hybrid-D

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdz119Licence: CC BY-NC-ND

mdz119Final published version, 145 KBLicence: CC BY-NC-ND

Cite this

Van Waalwijk Van Doorn-Khosrovani, S. B., Pisters-Van Roy, A., Van Saase, L., Van Der Graaff, M., Gijzen, J., Sleijfer, S., Hoes, L. R., Van Berge Henegouwen, J. M., Van Der Wijngaart, H., Van Der Velden, D. L., Van Werkhoven, E., Retel, V. P., Van Harten, W. H., Huitema, A. D. R., Timmers, L., Gelderblom, H., Verheul, H. M. W., & Voest, E. E. (2019). Personalised reimbursement: A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients. Annals of oncology, 30(5), 663-665. https://doi.org/10.1093/annonc/mdz119

@article{867aaee2081a47c1874493881e853813,

title = "Personalised reimbursement: A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients",

keywords = "UT-Hybrid-D",

author = "{Van Waalwijk Van Doorn-Khosrovani}, {S. B.} and {Pisters-Van Roy}, A. and {Van Saase}, L. and {Van Der Graaff}, M. and J. Gijzen and S. Sleijfer and Hoes, {L. R.} and {Van Berge Henegouwen}, {J. M.} and {Van Der Wijngaart}, H. and {Van Der Velden}, {D. L.} and {Van Werkhoven}, E. and Retel, {V. P.} and {Van Harten}, {W. H.} and Huitema, {A. D.R.} and L. Timmers and H. Gelderblom and Verheul, {H. M.W.} and Voest, {E. E.}",

note = "Oxford deal",

year = "2019",

month = may,

day = "1",

doi = "10.1093/annonc/mdz119",

language = "English",

volume = "30",

pages = "663--665",

journal = "Annals of oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "5",

}

Van Waalwijk Van Doorn-Khosrovani, SB, Pisters-Van Roy, A, Van Saase, L, Van Der Graaff, M, Gijzen, J, Sleijfer, S, Hoes, LR, Van Berge Henegouwen, JM, Van Der Wijngaart, H, Van Der Velden, DL, Van Werkhoven, E, Retel, VP, Van Harten, WH, Huitema, ADR, Timmers, L, Gelderblom, H, Verheul, HMW & Voest, EE 2019, 'Personalised reimbursement: A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients', Annals of oncology, vol. 30, no. 5, pp. 663-665. https://doi.org/10.1093/annonc/mdz119

TY - JOUR

T1 - Personalised reimbursement

T2 - A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients

AU - Van Waalwijk Van Doorn-Khosrovani, S. B.

AU - Pisters-Van Roy, A.

AU - Van Saase, L.

AU - Van Der Graaff, M.

AU - Gijzen, J.

AU - Sleijfer, S.

AU - Hoes, L. R.

AU - Van Berge Henegouwen, J. M.

AU - Van Der Wijngaart, H.

AU - Van Der Velden, D. L.

AU - Van Werkhoven, E.

AU - Retel, V. P.

AU - Van Harten, W. H.

AU - Huitema, A. D.R.

AU - Timmers, L.

AU - Gelderblom, H.

AU - Verheul, H. M.W.

AU - Voest, E. E.

N1 - Oxford deal

PY - 2019/5/1

Y1 - 2019/5/1

KW - UT-Hybrid-D

UR - http://www.scopus.com/inward/record.url?scp=85067377129&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdz119

DO - 10.1093/annonc/mdz119

M3 - Editorial

C2 - 31038154

AN - SCOPUS:85067377129

SN - 0923-7534

VL - 30

SP - 663

EP - 665

JO - Annals of oncology

JF - Annals of oncology

IS - 5

ER -

Personalised reimbursement: A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients

Keywords

UN SDGs

Access to Document

Other files and links

Cite this